NCT01130025 2025-02-24Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in CancerLEO PharmaPhase 3 Completed900 enrolled
NCT01583218 2023-08-07APEXAlexion Pharmaceuticals, Inc.Phase 3 Completed7,513 enrolled 18 charts 1 FDA
NCT02555878 2019-09-12A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer ParticipantsJanssen Research & Development, LLCPhase 3 Completed841 enrolled 24 charts
NCT00952380 2019-04-16Fragmin for the Treatment of Acute VTE in Pediatric Cancer PatientsPfizerPhase 2 Completed38 enrolled 30 charts
NCT02073682 2019-03-06Cancer Venous Thromboembolism (VTE)Daiichi SankyoPhase 3 Completed1,046 enrolled 24 charts
NCT01325558 2016-07-15A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsAltor BioSciencePhase 1 Completed30 enrolled
NCT00219973 2010-04-28CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)Rovi Pharmaceuticals LaboratoriesPhase 3 Completed526 enrolled
NCT00723216 2010-04-05Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer SurgerySanofiPhase 3 Completed151 enrolled